Nonalcoholic steatohepatitis (NASH) is an increasingly common cause of chronic liver disease worldwide. Currently, no specific pharmacologic therapy has been shown to treat NASH effectively. Because ...

This was an open, multicentre, observational study aimed at evaluating the effects of pioglitazone on blood pressure in a randomly selected population of diabetic patients with arterial hypertension.

Amsterdam, The Netherlands, Sept. 19, 2007 -- New research, including two studies presented this week at the 43rd Annual Meeting of the European Association for the Study of Diabetes (EASD), further ...

New research, including two studies presented this week at the 43rd Annual Meeting of the European Association for the Study of Diabetes (EASD), further support the cardiovascular safety of ACTOS(R) ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. Back to Healio In a new study, pioglitazone reduced the ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. Back to Healio Adults with type 2 diabetes randomly ...

Nonalcoholic steatohepatitis is a common liver disease that can progress to cirrhosis. Currently, there is no established treatment for this disease. We randomly assigned 247 adults with nonalcoholic ...

Orlando FL, June 5, 2004 – Type 2 diabetes and hypertension are commonly associated conditions, both of which carry an increased risk of cardiovascular disease. Results of a large, open-label, ...

In a new, proof-of-concept study, pioglitazone has been shown to lessen the metabolic and histologic abnormalities associated with nonalcoholic steatohepatitis (NASH), for which there is currently no ...

Women with polycystic ovary syndrome (PCOS) tend to be overweight and insulin-resistant, but pioglitazone treatment improves their insulin sensitivity, and leads to improved ovulatory function. High ...